Is Systematic Sextant Biopsy Suitable for the Detection of Clinically Significant Prostate Cancer?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Urol Int 2000;65:80–83, ISSN: 0042-1138
- Ereignis
-
Veröffentlichung
- (wo)
-
Dresden
- (wer)
-
Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
- (wann)
-
2014
- Ereignis
-
Veröffentlichung
- (wo)
-
Basel
- (wer)
-
Karger
- (wann)
-
2014
- Urheber
-
Manseck, Andreas
Fröhner, Michael
Oehlschläger, Sven
Hakenberg, Oliver
Friedrich, Katrin
Theissig, Franz
Wirth, Manfred P.
- URN
-
urn:nbn:de:bsz:14-qucosa-133885
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Manseck, Andreas
- Fröhner, Michael
- Oehlschläger, Sven
- Hakenberg, Oliver
- Friedrich, Katrin
- Theissig, Franz
- Wirth, Manfred P.
- Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
- Karger
Entstanden
- 2014
Ähnliche Objekte (12)
Metabolomics of clinically significant mTOR dysregulations
Prostate biopsy interpretation : an illustrated guide
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Managing clinically significant findings in research: The UK10K example
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy
Androgen receptor expression in the clinically localized prostate cancer
Individualized decision making in transperineal prostate biopsy: should all men undergo an additional systematic biopsy?
Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features
Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: performance of a fully automated AI‐algorithm for lesion detection and classification
Metabolomics of clinically significant mTOR dysregulations
Prostate biopsy interpretation : an illustrated guide
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Managing clinically significant findings in research: The UK10K example
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy
Androgen receptor expression in the clinically localized prostate cancer
Individualized decision making in transperineal prostate biopsy: should all men undergo an additional systematic biopsy?
Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features
Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: performance of a fully automated AI‐algorithm for lesion detection and classification
Metabolomics of clinically significant mTOR dysregulations
Prostate biopsy interpretation : an illustrated guide
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Managing clinically significant findings in research: The UK10K example
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsy
Androgen receptor expression in the clinically localized prostate cancer
Individualized decision making in transperineal prostate biopsy: should all men undergo an additional systematic biopsy?
Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features